Revealed Versus Concealed Cerebroplacental Ratio

• Register: ClinicalTrials.gov
• Last refreshed on: 25 April 2022
• Main ID: NCT02907242
• Date of registration: 01/08/2016
• Prospective Registration: No
• Primary sponsor: Hospital Clinic of Barcelona
• Public title: Revealed Versus Concealed Cerebroplacental Ratio
• Scientific title: Revealed Versus Concealed Criteria for Placental Insufficiency in Unselected Obstetric Population in Late Pregnancy: a Multicenter Randomized Controlled Trial
• Date of first enrolment: May 4, 2016
• Target sample size: 11582
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02907242
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Chile, Czech Republic, Czechia, Israel, Mexico, Poland, Spain, Switzerland

Contacts

• Name: Eduard Gratacos, PhD
• Affiliation: Hospital Clinic

Key inclusion & exclusion criteria

Inclusion Criteria:

- Viable singleton non-malformed fetus

- Available first-trimester US dating

- Maternal age at recruitment =18 years

- No adverse medical or obstetrical history at booking

- Capacity to give informed consent

Exclusion Criteria:

- Abnormal karyotype

- Structural abnormalities

- Congenital infections



Age minimum: 18 Years
Age maximum: 50 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Stillbirth

Intervention(s)

Other: Revealment

Primary Outcome(s)

Stillbirth [Time Frame: between 37 and 42 weeks of pregnancy]

Secondary Outcome(s)

Fetal Growth Restriction Detection [Time Frame: 3 years]

Adverse perinatal outcome [Time Frame: Up to 28 days after delivery]

Secondary ID(s)

RATIO37

Source(s) of Monetary Support

Please refer to primary and secondary sponsors